Links:
Ketamine-Induced Optimism: New Hope for the Development of Rapid-Acting Antidepressants - Gerard Sanatoria, MD, PhD, Psychiatric Times
Ketamine Works in OCD, Stubborn Depression - Physicians Weekly
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial - Biological Psychiatry Journal
Hope in Treatment-Refractory Depression - Brett Stetka, MD; David Feifel, MD, PhD - UCSD School of Medicine
Use and Safety of Ketamine: In Plain Terms - Juvenile Bipolar Research Foundation
Ketamine Works in OCD, Stubborn Depression - Physicians Weekly
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial - Biological Psychiatry Journal
Hope in Treatment-Refractory Depression - Brett Stetka, MD; David Feifel, MD, PhD - UCSD School of Medicine
Use and Safety of Ketamine: In Plain Terms - Juvenile Bipolar Research Foundation
Dr. Dennis Charney, MD - Psychiatrist & Neuroscientist
Dean, Mt. Sinai School of Medicine
Can Ketamine Treat Depression?
Published on Jul 16, 2014. Dr. Dennis Charney discusses recent research that shows that ketamine may be an effective treatment for depression in people who have been resistant to other treatments.
Published on Jul 16, 2014. Dr. Dennis Charney discusses recent research that shows that ketamine may be an effective treatment for depression in people who have been resistant to other treatments.
Yale Psychiatry |
National Institutes of Health -Intramural Research Program |
New Mechanisms Elicited with Ketamine in Treatment-Resistant Depression
Published on Oct 3, 2012. Ronald S. Duman, PhD, Elizabeth Mears and House Jameson Professor of Psychiatry and professor of neurobiology and of pharmacology at Yale School of Medicine, discusses advances in the treatment of depression. (April 2011) Skip to 15:43 mark for the discussion of Ketamine as an antidepressant. |
www.irp.nih.gov
Ketamine and Depression: From Despair to Hope in Hours Carlos Zarate, M.D., speeds up treatment for major depression at the National Institutes of Health (NIH) Intramural Research Program (IRP). Dr. Zarate is Chief of the Experimental Therapeutics & Pathophysiology Branch and the Section on the Neurobiology and Treatment of Mood Disorders at the National Institute of Mental Health (NIMH). |
|
|